Sourcing Survey 2022 - Moving Home?

Sourcing Survey 2022 – Moving Home?

Asia Perspective Sourcing Survey 2022

ARC Consulting (formerly Asia Perspective) has conducted sourcing surveys since 2013, aiming to measure the perception of Asia as a sourcing market, and how this perception is changing over time. In 2022, the survey focused on reshoring trends, examining to what extent companies are relocating, where they choose to move and what motivates their decisions.

Download the Sourcing Survey PDF

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission